Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non-Hodgkin lymphoma

British Journal of Haematology

Volumn 148, Issue 5, 2010, Pages 808-810

  García Suárez, Julio ^a   Martín, Yolanda ^a   Callejas, Marta ^a   Rodriguez Dominguez, Mario ^b   Galán, Juan Carlos ^b   Burgaleta, Carmen ^a  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Aggressive non Hodgkin lymphoma; Influenza A H1N1 2009 virus; Oseltamivir; Pneumonia; Splenectomy

Indexed keywords

CASPOFUNGIN; CEFDITOREN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MEROPENEM; OSELTAMIVIR; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTERIAL INFECTION; BLOOD CELL COUNT; BODY TEMPERATURE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFLUENZA; INFLUENZA H1N1; INFLUENZA VIRUS A; LARGE CELL LYMPHOMA; LETTER; LUNG LAVAGE; MALE; NONHODGKIN LYMPHOMA; OXYGEN SATURATION; PHYSICAL EXAMINATION; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; SPLENECTOMY; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANEMIA, HEMOLYTIC; ANTIVIRAL AGENTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; OSELTAMIVIR; PNEUMONIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLENECTOMY;

EID: 76449094702     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07997.x     Document Type: Letter

References (8)

1. Centers for Disease Control and Prevention (CDC) (2009) Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients. MMWR Morbidity and Mortality Weekly Report, 58, 893 896.
2. Chemaly, R.F., Ghosh, S., Bodey, G.P., Rohatgi, N., Safdar, A., Keating, M.J., Champlin, R.E., Aguilera, E.A., Tarrand, J.J. Raad, I.I. (2006) Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore), 85, 278 287.
3. García-Suárez, J., Gil-Fernández, J.J., Martín, Y., Callejas, M., Magro, H., López-Rubio, M., Calero, M.A. Burgaleta, C. (2009) Dose-adjusted R-EDOCH-14 supported by pegfilgrastrim or filgrastrim in patients with high-risk diffuse large B-cell lymphoma (DLBCL): feasibility and preliminary efficacy. Haematologica, 94, 1711a. [abstract].
4. Gooskens, J., Jonges, M., Claas, E.C., Meijer, A. Kroes, A.C. (2009) Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. The Journal of Infectious Diseases, 199, 1435 1441.
5. Kobayashi, S., Kimura, F., Kobayashi, A., Sato, K. Motoyoshi, K. (2008) Influenza virus reactivation after remission with oseltamivir treatment in a patient undergoing nonmyeloablative bone marrow transplantation. Journal of Infection and Chemotherapy, 14, 308 310.
6. Moscona, A. (2005) Neuraminidase inhibitors for influenza. The New England Journal of Medicine, 353, 1363 1373.
7. Nicoll, A. Coulombier, D. (2009) Europe's initial experience with pandemic (H1N1) 2009-mitigation and delaying policies and practices. Eurosurveillance, 14, 1 6.
8. Wade, J.C. (2006) Viral infections in patients with hematological malignancies. Hematology/American Society of Hematology. Education Program, 2006, 368 374.